НовостиBenzingaBlossomHill Therapeutics Announces Alignment With FDA On 50mg Twice Daily As Recommended Phase 2 Dose For BH-30643 BlossomHill Therapeutics Announces Alignment With FDA On 50mg Twice Daily As Recommended Phase 2 Dose For BH-30643 Benzinga 2026.11.09 12:17 (GMT+0) Открыть на Benzinga Другие новости